Global Health Impacts of Vector-Borne Diseases Workshop Summary (2016) / Chapter Skim
Currently Skimming:
Appendix E: Speaker Biographies
Appendix E: Speaker Biographies
Pages 363-372
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 363... ...
Oxitec aims to control insect pests by use of engineered sterile males of the pest insect species (RIDL males)
|
From page 364... ...
a metabolomicsbased LC-MS/MS approach for identification of small molecular biomarkers in acute phase serum, urine, and saliva for diagnosis of dengue virus infections and for prognosis of severe disease outcomes (dengue hemorrhagic fever and shock syndrome; (2) molecular mosquitocides (a novel RNAi-nanoparticle, target-specific approach)
|
From page 365... ...
As part of his responsibilities, he was involved in development of the Connecticut response to a wide range of emerging infectious disease issues, including HIV, tuberculosis, and Lyme disease in the 1980s; West Nile virus in 1999; anthrax in 2001; and SARS in 2003. He also was the principal investigator for the Connecticut Emerging Infections Program from 1995–2007 and responsible for public health preparedness activities relating to infectious diseases.
|
From page 366... ...
He was the recipient of the John I Davidson Award for Practical Papers by the American Society for Photogrammetric Engineering and Remote Sensing, the 2010 Federal Laboratory Consortium Lab Director of Year award, a 2013 Finalist for the Samuel J Heyman Service to America Awards National Security and International Affairs Medal, and is president-elect of the American Mosquito Control Association.
|
From page 367... ...
While at PDVI, the program advanced five dengue vaccines into clinical trials, evaluated the performance of commercially available dengue diagnostic tests, established potential vaccine trial sites, and established regional public health networks to support introduction of dengue vaccines. Margolis is a fellow of the American Academy of Pediatrics and Infectious Diseases Society of America.
|
From page 368... ...
He completed his residency in anatomic pathology L and laboratory medicine at the University of California, San Francisco, in 1995. His employment with CDC began in 1996, as medical officer in the Viral and Rickettsial Zoonoses Branch, where he worked until taking a position as staff pathologist with the Infectious Disease Pathology Branch from 2003 to 2014.
|
From page 369... ...
After being raised in a small city in northern Mexico, she was inspired to become a virologist after seeing the impact of rabies virus on animals and humans in the area and the extensive effects of an epidemic of Venezuelan equine encephalitis virus on equids in Mexico and Texas. She did her theses research on equine encephalitis viruses, and worked on these, dengue, and other viral hemorrhagic fever viruses at the Yale Arbovirus Research Unit and in the BSL4 laboratory at TBRI.
|
From page 370... ...
She serves on advisory committees for blood centers internationally and diagnostic test kit manufacturers. She received numerous American Red Cross awards including the President's Award.
|
From page 371... ...
as a control strategy and a functional genomics tool for arthropod vectors of plant pathogens.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.